甲状腺和其他内分泌腺恶性肿瘤的临床试验
总计10205个结果
-
Gustave Roussy, Cancer Campus, Grand Paris终止
-
Mayo ClinicNational Cancer Institute (NCI)招聘中
-
Fujian Medical University完全的
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Iovance Biotherapeutics, Inc.主动,不招人恶性实体肿瘤 | 软组织肉瘤 | 复发性卵巢癌 | 三阴性乳腺癌 | 复发性骨肉瘤 | 难治性骨肉瘤 | 骨肉瘤 | 骨巨细胞瘤 | 卵巢癌肉瘤 | 铂类耐药卵巢癌 | 去分化软骨肉瘤 | 骨巨细胞瘤的恶性程度 | 低分化甲状腺癌 | 甲状腺间变性癌 | 甲状腺鳞状细胞癌 | 未分化高级别多形性骨肉瘤美国
-
University of Texas Southwestern Medical CenterAkrimax Pharmaceuticals终止
-
Nanjing First Hospital, Nanjing Medical University未知
-
The First Affiliated Hospital of Xiamen University招聘中
-
Gustave Roussy, Cancer Campus, Grand Paris主动,不招人RAS 或 BRAF 突变的转移性放射性碘难治性甲状腺癌患者法国
-
Cyprus University of TechnologyBank of Cyprus Oncology Centre完全的
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)主动,不招人低分化甲状腺癌 | 甲状腺间变性癌 | 不可切除的甲状腺癌 | 转移性甲状腺癌 | IVB 期甲状腺间变性癌 AJCC v8 | IVC 期甲状腺间变性癌 AJCC v8 | IVA 期甲状腺间变性癌 AJCC v8美国
-
Mateon Therapeutics终止
-
Alberta Health services完全的
-
Centre Francois BaclesseFrench cancer Institute INCa招聘中
-
Yonsei University完全的
-
National Cancer Center Hospital EastOno Pharmaceutical Co. Ltd主动,不招人
-
Translational Research Center for Medical Innovation...完全的
-
Northwestern UniversityNational Cancer Institute (NCI)招聘中
-
Dana-Farber Cancer InstituteMillennium Pharmaceuticals, Inc.完全的